Triostat

Active Ingredient(s): Liothyronine
FDA Approved: * December 31, 1991
Pharm Company: * JONES PHARMA
Category: Thyroid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Triostat Overview

Liothyronine is a synthetic form of triiodothyronine (T3), a thyroid hormone used to treat hypothyroidism and myxedema coma. T3 is the metabolically active thyroid hormone, which causes feedback inhibition, and lowers elevated TSH levels. It increases metabolism in peripheral tissues and is indicated when there is an impaired conversion of T4 to T3 in peripheral tissues. It is also used as an augmentation strategy in treating major depressive disorder when used in combination with antidepress...

Read more Triostat Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Liothyronine

Recent Triostat Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Triostat: (1 result)

Sorted by National Drug Code

• 42023-120 Triostat 10 ug/ml Intravenous Injection by Jhp Pharmaceuticals LLC

Other drugs which contain Liothyronine or a similar ingredient: (2 results)

• CYTOMEL Liothyronine13 discussions
• LIOTHYRONINE 5 discussions